SCHEMBL5820469

SCHEMBL5820469

O=C(c1cccc(F)c1F)N1CC2(CCN(CCCC[AsH2])CC2)c2cc(Cl)ccc21

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.47
NOTUM Q6P988 1/20 0.43
ATM Q13315 1/20 0.36
SLC18A3 Q16572 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
P2RX7 Q99572 1/20 0.35
HTR1A P08908 1/20 0.35
DRD1 P21728 1/20 0.35
DRD4 P21917 1/20 0.35
ADRA1D P25100 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
DRD3 P35462 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5578564 0.92 DRD2 (0.47) DRD2NOTUMATMSLC18A3SIGMAR1
SCHEMBL5578732 0.91 DRD2 (0.48) DRD2NOTUMATMSLC18A3SIGMAR1
SCHEMBL5579121 0.88 DRD2 (0.45) DRD2NOTUMATMSLC18A3SIGMAR1
SCHEMBL5579075 0.88 DRD2 (0.45) DRD2NOTUMATMSLC18A3SIGMAR1
SCHEMBL5578852 0.88 DRD2 (0.48) DRD2NOTUMHTR1ADRD4HTR2A
SCHEMBL4893188 0.87 NOTUM (0.43) DRD2NOTUMATMPTGDR2P2RX7
SCHEMBL5578890 0.86 DRD2 (0.46) DRD2NOTUMDRD4DRD3
SCHEMBL5578519 0.84 KDM4E (0.50) DRD2NOTUMSIGMAR1PTGDR2
SCHEMBL5578496 0.83 NOTUM (0.46) DRD2NOTUMATMPTGDR2P2RX7
SCHEMBL5579087 0.83 NOTUM (0.43) DRD2NOTUMSIGMAR1PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1716148-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF Arena Pharmaceuticals, Inc. (US) 2006-11-02 EP claimed
WO-2005063745-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARMACEUTICALS, INC. (US) 2005-07-14 WO claimed